Cags and acs evidence based reviews in surgery. 48.: What is the effect of screening mammography on breast cancer incidence?

Canadian Journal of Surgery

Volumn 57, Issue 1, 2014, Pages 67-69

  Latosinsky, Steve ^a   Boileau, Jean Francois ^a   Bryant, Heather E ^a   Newman, Lisa A ^a   Baxter, N N ^a   Brasel, K J ^a   Brown, C J ^a   Chaudhury, P K ^a   Divino, C M ^a   Dixon, E ^a   Fitzgerald, G W N ^a   Hameed, S M ^a   Henteleff, H J ^a   Hughes, T G ^a   Kao, L S ^a   Kirkpatrick, A W ^a   Latosinsky, S ^a   Mastracci, T M ^a   McLeod, R S ^a   Morris, A M ^a   Pawlik, T M ^a   Temple, L K ^a   McKenzie, M E ^a   more..

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST TUMOR; EARLY DIAGNOSIS; FEMALE; HUMAN; MAMMOGRAPHY; NOTE;

BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAMMOGRAPHY;

EID: 84893860793     PISSN: 0008428X     EISSN: 14882310     Source Type: Journal    
DOI: 10.1503/cjs.032913     Document Type: Article

References (17)

1. Evidence-Based Medicine Working Group. Evidence-based medicine. JAMA 1992;268:2420-5.
2. Autier P, Boniol M. The incidence of advanced breast cancer in the West Midlands, United Kingdom. Eur J Cancer Prev 2012;21:217-21.
3. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 2012;367:1998-2005.
4. Centers of Disease Control and Prevention. National Health Interview Survey. Available: http://www.cdc.gov/nchs/nhis.htm (accessed 2013 Nov. 15).
5. Nolan M, Michaelson JS. SEER Breast Cancer Database, 2007: Creation and characterization [report]. Boston: Massachusetts General Hospital, Department of Surgical Oncology, Center for Quantitative Medicine; 1998. Available: www.lifemath.net/cancer/about/techreports/technical-report-7b.pdf (accessed 2013 Nov. 15).
6. Narod SA. Hormone replacement therapy and the risk of breast cancer. Nat Rev Clin Oncol 2011;8:669-76.
7. Giuliano AE, Dale PS, Turner RR, et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995;222:394-399.
8. Tvedskov T F. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection. Dan Med J 2012;59:B4475.
9. Jemal A, Ward E, Thun MJ. Recent trends in breast cancer incidence rates by age and tumor characteristics among U. S. women. Breast Cancer Res 2007;9:R28.
10. Cancer Care Ontario. Breast Cancer Evidence-based Series (EBS) and Practice Guidelines (PG). Available: www.cancercare.on.ca/toolbox/ qualityguidelines/diseasesite/breast-ebs/ (accessed 2013 Nov. 15).
11. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology Breast Cancer. Fort Washington (PA): The Network; 2013. Available: www.nccn.org/professionals/physician-gls/pdf/breast.pdf [Subscription required to access content].
12. Kinsinger LS, Harris R, Woolf SH, et al. Chemopreveniton of breast cancer: a summary of evidence for U. S. Preventive Service Task Force. Ann Intern Med 2002;137:59-69.
13. McKay A, Martin W, Latosinsky S. How should we inform women at higher risk of breast cancer about tamoxifen? An approach with a decision guide. Breast Cancer Res Treat 2005;94:153-9.
14. U. S. Preventative Services Task Force. Screening for breast cancer: U. S. Preventative Services Task Force Recommendation Statement. Ann Intern Med 2009;151:716-26.
15. The Canadian Task Force on Preventative Healthcare. Recommendations on screening for breast cancer in average-risk women aged 40-74 years. CMAJ 2011;183:1991-2001.
16. Mandelblatt JS, Cronin JA, Bailey S, et al. Effects of mammographic screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med 2009;151:738-47.
17. Jørgensen KJ, Gotzsche PC. Effect of screening mammography on breast cancer incidence. N Engl J Med 2013;368:677-8.